Analysis of a focused set of compounds, blinded to name and structure, from Sponsor's internal compound collection for in vitro antiviral activity in UTMB's assay against SARS-CoV2/COVID-19

Project: Other project

Project Details

StatusActive
Effective start/end date6/11/2012/31/20

Funding

  • Merck Sharp & Dohme Corporation: $180,000.00